1. Home
  2. ZLAB vs NEA Comparison

ZLAB vs NEA Comparison

Compare ZLAB & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • NEA
  • Stock Information
  • Founded
  • ZLAB 2013
  • NEA 2002
  • Country
  • ZLAB China
  • NEA United States
  • Employees
  • ZLAB N/A
  • NEA N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • NEA Finance/Investors Services
  • Sector
  • ZLAB Health Care
  • NEA Finance
  • Exchange
  • ZLAB Nasdaq
  • NEA Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • NEA 3.3B
  • IPO Year
  • ZLAB 2017
  • NEA N/A
  • Fundamental
  • Price
  • ZLAB $35.19
  • NEA $10.89
  • Analyst Decision
  • ZLAB Buy
  • NEA
  • Analyst Count
  • ZLAB 5
  • NEA 0
  • Target Price
  • ZLAB $54.28
  • NEA N/A
  • AVG Volume (30 Days)
  • ZLAB 689.4K
  • NEA 803.4K
  • Earning Date
  • ZLAB 08-07-2025
  • NEA 01-01-0001
  • Dividend Yield
  • ZLAB N/A
  • NEA 4.23%
  • EPS Growth
  • ZLAB N/A
  • NEA N/A
  • EPS
  • ZLAB N/A
  • NEA N/A
  • Revenue
  • ZLAB $418,326,000.00
  • NEA N/A
  • Revenue This Year
  • ZLAB $44.07
  • NEA N/A
  • Revenue Next Year
  • ZLAB $49.13
  • NEA N/A
  • P/E Ratio
  • ZLAB N/A
  • NEA N/A
  • Revenue Growth
  • ZLAB 43.72
  • NEA N/A
  • 52 Week Low
  • ZLAB $16.01
  • NEA $9.20
  • 52 Week High
  • ZLAB $44.34
  • NEA $11.37
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.90
  • NEA 49.47
  • Support Level
  • ZLAB $32.31
  • NEA $10.92
  • Resistance Level
  • ZLAB $35.72
  • NEA $11.04
  • Average True Range (ATR)
  • ZLAB 1.10
  • NEA 0.05
  • MACD
  • ZLAB -0.34
  • NEA 0.00
  • Stochastic Oscillator
  • ZLAB 60.17
  • NEA 49.08

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.

Share on Social Networks: